These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22659199)

  • 1. Personalized medicine: hope or hype?
    Salari K; Watkins H; Ashley EA
    Eur Heart J; 2012 Jul; 33(13):1564-70. PubMed ID: 22659199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized genomes and cardiovascular disease.
    Musunuru K
    Cold Spring Harb Perspect Med; 2014 Sep; 5(1):a014068. PubMed ID: 25256177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease gets personal.
    Hayden EC
    Nature; 2009 Aug; 460(7258):940-1. PubMed ID: 19693052
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
    Zaiou M; El Amri H
    Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.
    George J; Doney A; Palmer CN; Lang CC
    Cardiovasc Ther; 2010 Jun; 28(3):135-8. PubMed ID: 20557312
    [No Abstract]   [Full Text] [Related]  

  • 6. Stroke genetics: prospects for personalized medicine.
    Markus HS
    BMC Med; 2012 Sep; 10():113. PubMed ID: 23016624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
    Donohue MM; Tirschwell DL
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):52-60. PubMed ID: 21046289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.
    Ross S; Paré G
    Pharmacogenomics; 2013 Oct; 14(13):1565-72. PubMed ID: 24088127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
    Pulley JM; Denny JC; Peterson JF; Bernard GR; Vnencak-Jones CL; Ramirez AH; Delaney JT; Bowton E; Brothers K; Johnson K; Crawford DC; Schildcrout J; Masys DR; Dilks HH; Wilke RA; Clayton EW; Shultz E; Laposata M; McPherson J; Jirjis JN; Roden DM
    Clin Pharmacol Ther; 2012 Jul; 92(1):87-95. PubMed ID: 22588608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.
    Predazzi IM; Mango R; Norata GD; Di Daniele N; Sergi D; Romeo F; Novelli G
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):79-85. PubMed ID: 23539170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of pharmacogenetics: present and near future.
    Gladding PA
    Cleve Clin J Med; 2013 Aug; 80(8):477-82. PubMed ID: 23908102
    [No Abstract]   [Full Text] [Related]  

  • 12. Personalized genomic medicine.
    Novelli G
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S81-90. PubMed ID: 20865479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.
    Shuldiner AR; Palmer K; Pakyz RE; Alestock TD; Maloney KA; O'Neill C; Bhatty S; Schub J; Overby CL; Horenstein RB; Pollin TI; Kelemen MD; Beitelshees AL; Robinson SW; Blitzer MG; McArdle PF; Brown L; Jeng LJ; Zhao RY; Ambulos N; Vesely MR
    Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):76-84. PubMed ID: 24616408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of genetic data to guide therapy in arterial disease.
    Ross S; Nejat S; Paré G
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S281-9. PubMed ID: 26149037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of genetics and transcriptomics in the diagnosis and treatment of coronary artery disease.
    Freedman JE; Iafrati HF
    Rev Esp Cardiol; 2010 Oct; 63(10):1123-6. PubMed ID: 20875351
    [No Abstract]   [Full Text] [Related]  

  • 16. Personalized approaches to clopidogrel therapy: are we there yet?
    Anderson CD; Biffi A; Greenberg SM; Rosand J
    Stroke; 2010 Dec; 41(12):2997-3002. PubMed ID: 21030701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine: hope or hype.
    Wald NJ; Morris JK
    Eur Heart J; 2012 Jul; 33(13):1553-4. PubMed ID: 22659200
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.
    Berinstein E; Levy A
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):973-983. PubMed ID: 28792790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel: to test or not to test? That is the question--still.
    Cannon CP
    Clin Chem; 2011 May; 57(5):659-61. PubMed ID: 21402801
    [No Abstract]   [Full Text] [Related]  

  • 20. Clopidogrel pharmacogenetics: from evidence to implementation.
    Cavallari LH; Duarte JD
    Future Cardiol; 2016 Sep; 12(5):511-4. PubMed ID: 27539287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.